Pfatp6 molecular profile of Plasmodium falciparum isolates in the western Brazilian Amazon
Authors:
- Larissa W BrasilLBLarissa W Brasil
- André Ll AreasAAAndré Ll Areas
- Gisely C MeloGMGisely C Melo
- Cintia MC OliveiraCOCintia MC Oliveira
- Maria G C AlecrimMAMaria G C Alecrim
- Marcus V G LacerdaMLMarcus V G Lacerda
- Connor O'BrienCOConnor O'Brien
- Walter Mr OelemannWOWalter Mr Oelemann
- Mariano G ZalisMZMariano G Zalis
Open Access
- 10 April 2012
- journal article
- Published by Springer Nature in Malaria Journal
- Vol. 11 (1) , 111
Abstract
Anti-malarial drug resistance has emerged as one of the biggest challenges confronting the worldwide effort to control malaria. The appearance of chloroquine and multi-drug resistance had devastating effects on therapeutic efficacy of former first-line agents. Artemisinin has proven to be an excellent therapeutic alternative to fill the void in chemotherapeutic options left by resistance mechanisms. At the time of introduction, no resistance to artemisinins had been recorded, and artemisinins demonstrated excellent parasite reduction rates. In an attempt to protect artemisinin efficacy, the World Health Organization (WHO) made artemisinin-based combination therapy (ACT) its official first-line treatment recommendation for uncomplicated Plasmodium falciparum in 2006. In Brazil, artemether/lumefantrine became the Brazilian Malaria Control Programme's official treatment recommendation in 2007. The sarco/endoplasmic reticulum Ca2+ - ATPase ortholog of P. falciparum (pfatp6) has been suggested as one of the targets of artemisinins. Consequently, pfatp6 gene polymorphisms are being investigated as markers of artemisinin resistance elsewhere. The goal of this work was to describe the molecular profile of pfatp6 in P. falciparum isolates from different localities in the Amazonas State.Keywords
This publication has 13 references indexed in Scilit:
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- Diversity of the sarco/endoplasmic reticulum Ca2+-ATPase orthologue of Plasmodium falciparum (PfATP6)Infection, Genetics and Evolution, 2008
- Plasmodium falciparum from Pará state (Brazil) shows satisfactory in vitro response to artemisinin derivatives and absence of the S769N mutation in the SERCA‐type PfATPase6Tropical Medicine & International Health, 2008
- In vitro assessment of artesunate, artemether and amodiaquine susceptibility and molecular analysis of putative resistance‐associated mutations of Plasmodium falciparum from São Tomé and PríncipeTropical Medicine & International Health, 2007
- Resistance to DihydroartemisininEmerging Infectious Diseases, 2006
- Malaria Parasites Can Develop Stable Resistance to Artemisinin but Lack Mutations in Candidate Genes atp6 (Encoding the Sarcoplasmic and Endoplasmic Reticulum Ca 2+ ATPase), tctp , mdr1 , and cg10Antimicrobial Agents and Chemotherapy, 2006
- Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6The Lancet, 2005
- Quinolines and Artemisinin: Chemistry, Biology and History2005
- Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy numberThe Lancet, 2004
- Artemisinins target the SERCA of Plasmodium falciparumNature, 2003